185 related articles for article (PubMed ID: 9738576)
1. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Pietersen AM; Theunissen PH; Thunnissen FB
J Clin Oncol; 1998 Sep; 16(9):3061-8. PubMed ID: 9738576
[TBL] [Abstract][Full Text] [Related]
2. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Thunnissen FB
Methods Mol Med; 2003; 75():305-23. PubMed ID: 12407749
[No Abstract] [Full Text] [Related]
3. Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours.
Somers VA; van Henten AM; ten Velde GP; Arends JW; Thunnissen FB
Eur Respir J; 1999 May; 13(5):1120-4. PubMed ID: 10414414
[TBL] [Abstract][Full Text] [Related]
4. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
[TBL] [Abstract][Full Text] [Related]
5. Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer.
Zhang LF; Gao WM; Gealy R; Weissfeld J; Elder E; Whiteside TL; Keohavong P
Biomarkers; 2003; 8(2):156-61. PubMed ID: 12775500
[TBL] [Abstract][Full Text] [Related]
6. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
[TBL] [Abstract][Full Text] [Related]
8. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Point-EXACCT method in non-small cell lung carcinomas.
Somers VA; Leimbach DA; Theunissen PH; Murtagh JJ; Holloway B; Ambergen AW; Thunnissen FB
Clin Chem; 1998 Jul; 44(7):1404-9. PubMed ID: 9665416
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.
Graziano SL; Gamble GP; Newman NB; Abbott LZ; Rooney M; Mookherjee S; Lamb ML; Kohman LJ; Poiesz BJ
J Clin Oncol; 1999 Feb; 17(2):668-75. PubMed ID: 10080613
[TBL] [Abstract][Full Text] [Related]
11. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
13. K-ras gene mutation in sputum samples containing atypical cells and adenocarcinoma cells in the lung.
Shiono S; Omoe K; Endo A
Carcinogenesis; 1996 Aug; 17(8):1683-6. PubMed ID: 8761426
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR
Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.
Zhang L; Gao W; Keohavong P
Methods Mol Biol; 2020; 2102():373-394. PubMed ID: 31989568
[TBL] [Abstract][Full Text] [Related]
16. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).
Takeda S; Ichii S; Nakamura Y
Hum Mutat; 1993; 2(2):112-7. PubMed ID: 8318987
[TBL] [Abstract][Full Text] [Related]
17. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
Zhang G; Sun Y; Wang M
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
[TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
19. K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report.
Kovalchuk O; Naumnik W; Serwicka A; Chyczewska E; Niklinski J; Chyczewski L
Folia Histochem Cytobiol; 2001; 39 Suppl 2():70-2. PubMed ID: 11820633
[TBL] [Abstract][Full Text] [Related]
20. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
